Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes

BACKGROUND AND AIM: Sodium glucose cotransporter 2 inhibitors (SGLT‐2i), by way of their unique mode of action, present an attractive strategy for the treatment of type 2 diabetes and non‐alcoholic fatty liver disease (NAFLD), which often coexist and may lead to severe complications. However, the ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Binayak, Datta, Debasis, Ghosal, Samit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857274/
https://www.ncbi.nlm.nih.gov/pubmed/33553659
http://dx.doi.org/10.1002/jgh3.12473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857274/
https://www.ncbi.nlm.nih.gov/pubmed/33553659
http://dx.doi.org/10.1002/jgh3.12473

Ejemplares similares